94 related articles for article (PubMed ID: 25946325)
1. Stress response and expression of fluconazole resistance associated genes in the pathogenic yeast Candida glabrata deleted in the CgPDR16 gene.
Culakova H; Dzugasova V; Valencikova R; Gbelska Y; Subik J
Microbiol Res; 2015 May; 174():17-23. PubMed ID: 25946325
[TBL] [Abstract][Full Text] [Related]
2. Mutation of the CgPDR16 gene attenuates azole tolerance and biofilm production in pathogenic Candida glabrata.
Culakova H; Dzugasova V; Perzelova J; Gbelska Y; Subik J
Yeast; 2013 Oct; 30(10):403-14. PubMed ID: 23939632
[TBL] [Abstract][Full Text] [Related]
3. Mutations in the CgPDR1 and CgERG11 genes in azole-resistant Candida glabrata clinical isolates from Slovakia.
Berila N; Borecka S; Dzugasova V; Bojnansky J; Subik J
Int J Antimicrob Agents; 2009 Jun; 33(6):574-8. PubMed ID: 19196495
[TBL] [Abstract][Full Text] [Related]
4. Pdr1 regulates multidrug resistance in Candida glabrata: gene disruption and genome-wide expression studies.
Vermitsky JP; Earhart KD; Smith WL; Homayouni R; Edlind TD; Rogers PD
Mol Microbiol; 2006 Aug; 61(3):704-22. PubMed ID: 16803598
[TBL] [Abstract][Full Text] [Related]
5. Disclosing azole resistance mechanisms in resistant Candida glabrata strains encoding wild-type or gain-of-function CgPDR1 alleles through comparative genomics and transcriptomics.
Salazar SB; Pinheiro MJF; Sotti-Novais D; Soares AR; Lopes MM; Ferreira T; Rodrigues V; Fernandes F; Mira NP
G3 (Bethesda); 2022 Jul; 12(7):. PubMed ID: 35532173
[TBL] [Abstract][Full Text] [Related]
6. Comparative genomic and transcriptomic analyses unveil novel features of azole resistance and adaptation to the human host in Candida glabrata.
Salazar SB; Wang C; Münsterkötter M; Okamoto M; Takahashi-Nakaguchi A; Chibana H; Lopes MM; Güldener U; Butler G; Mira NP
FEMS Yeast Res; 2018 Feb; 18(1):. PubMed ID: 29087506
[TBL] [Abstract][Full Text] [Related]
7. Contribution of CgPDR1-regulated genes in enhanced virulence of azole-resistant Candida glabrata.
Ferrari S; Sanguinetti M; Torelli R; Posteraro B; Sanglard D
PLoS One; 2011 Mar; 6(3):e17589. PubMed ID: 21408004
[TBL] [Abstract][Full Text] [Related]
8. Fluconazole-induced actin cytoskeleton remodeling requires phosphatidylinositol 3-phosphate 5-kinase in the pathogenic yeast Candida glabrata.
Bhakt P; Shivarathri R; Choudhary DK; Borah S; Kaur R
Mol Microbiol; 2018 Nov; 110(3):425-443. PubMed ID: 30137648
[TBL] [Abstract][Full Text] [Related]
9. The Absence of PDR16 Gene Restricts the Overexpression of CaSNQ2 Gene in the Presence of Fluconazole in Candida albicans.
Bencova A; Goffa E; Morvova M; Valachovic M; Griač P; Toth Hervay N; Gbelska Y
Mycopathologia; 2020 Jun; 185(3):455-465. PubMed ID: 32451851
[TBL] [Abstract][Full Text] [Related]
10. The yeast Saccharomyces cerevisiae Pdr16p restricts changes in ergosterol biosynthesis caused by the presence of azole antifungals.
Šimová Z; Poloncová K; Tahotná D; Holič R; Hapala I; Smith AR; White TC; Griač P
Yeast; 2013 Jun; 30(6):229-41. PubMed ID: 23606207
[TBL] [Abstract][Full Text] [Related]
11. The ATP-binding cassette transporter-encoding gene CgSNQ2 is contributing to the CgPDR1-dependent azole resistance of Candida glabrata.
Torelli R; Posteraro B; Ferrari S; La Sorda M; Fadda G; Sanglard D; Sanguinetti M
Mol Microbiol; 2008 Apr; 68(1):186-201. PubMed ID: 18312269
[TBL] [Abstract][Full Text] [Related]
12. CgPDR1 gain-of-function mutations lead to azole-resistance and increased adhesion in clinical Candida glabrata strains.
Ni Q; Wang C; Tian Y; Dong D; Jiang C; Mao E; Peng Y
Mycoses; 2018 Jul; 61(7):430-440. PubMed ID: 29464833
[TBL] [Abstract][Full Text] [Related]
13. Two Functionally Redundant FK506-Binding Proteins Regulate Multidrug Resistance Gene Expression and Govern Azole Antifungal Resistance.
Moirangthem R; Kumar K; Kaur R
Antimicrob Agents Chemother; 2021 May; 65(6):. PubMed ID: 33722894
[TBL] [Abstract][Full Text] [Related]
14. Candida glabrata--unique features and challenges in the clinical management of invasive infections.
Glöckner A; Cornely OA
Mycoses; 2015 Aug; 58(8):445-50. PubMed ID: 26207423
[TBL] [Abstract][Full Text] [Related]
15. PDR16-mediated azole resistance in Candida albicans.
Saidane S; Weber S; De Deken X; St-Germain G; Raymond M
Mol Microbiol; 2006 Jun; 60(6):1546-62. PubMed ID: 16796687
[TBL] [Abstract][Full Text] [Related]
16. Fungaemia caused by Candida glabrata with reduced susceptibility to fluconazole due to altered gene expression: risk factors, antifungal treatment and outcome.
Tumbarello M; Sanguinetti M; Trecarichi EM; La Sorda M; Rossi M; de Carolis E; de Gaetano Donati K; Fadda G; Cauda R; Posteraro B
J Antimicrob Chemother; 2008 Dec; 62(6):1379-85. PubMed ID: 18782778
[TBL] [Abstract][Full Text] [Related]
17. Doxorubicin selects for fluconazole-resistant petite mutants in Candida glabrata isolates.
Schulz B; Knobloch M; Weber K; Ruhnke M
Int J Med Microbiol; 2012 Jul; 302(3):155-61. PubMed ID: 22664377
[TBL] [Abstract][Full Text] [Related]
18. Membrane Proteome-Wide Response to the Antifungal Drug Clotrimazole in Candida glabrata: Role of the Transcription Factor CgPdr1 and the Drug:H+ Antiporters CgTpo1_1 and CgTpo1_2.
Pais P; Costa C; Pires C; Shimizu K; Chibana H; Teixeira MC
Mol Cell Proteomics; 2016 Jan; 15(1):57-72. PubMed ID: 26512119
[TBL] [Abstract][Full Text] [Related]
19. Local silencing controls the oxidative stress response and the multidrug resistance in Candida glabrata.
Orta-Zavalza E; Guerrero-Serrano G; Gutiérrez-Escobedo G; Cañas-Villamar I; Juárez-Cepeda J; Castaño I; De Las Peñas A
Mol Microbiol; 2013 Jun; 88(6):1135-48. PubMed ID: 23651300
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of the Candida glabrata CgRTA1 and CgRSB1 genes in response to various stress conditions.
Kołaczkowska A; Dyląg M; Kołaczkowski M
Biochem Biophys Res Commun; 2013 Mar; 432(1):169-74. PubMed ID: 23337499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
